A detailed history of Cibc Private Wealth Group, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 675 shares of MRVI stock, worth $3,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares
675
Holding current value
$3,273
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $4,617 - $6,567
675 New
675 $5,000
Q3 2021

Nov 12, 2021

SELL
$36.8 - $60.62 $3.28 Million - $5.41 Million
-89,192 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.46 - $45.0 $372,705 - $516,690
11,482 Added 14.78%
89,192 $3.72 Million
Q1 2021

May 12, 2021

BUY
$25.8 - $38.49 $2 Million - $2.99 Million
77,710 New
77,710 $2.77 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $638M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.